CXCL1 and cancer: Consistent with our findings, other chemodrugs, including doxorubicin, carboplatin, oxaliplatin, and gemcitabine, have been reported to induce the secretion of CXCL1 from cancer cells and therefore to mediate the emergence of cancer chemoresistance (Korbecki et al., 2023).